Safety and Efficacy of Apremilast in Plaque Psoriasis With Special Area Involvement

Apremilast (Otezla) significantly improved quality of life (QoL) in people with plaque psoriasis in „special areas“ of the body.

This is the key take-home message from a phase 4, randomized controlled trial that enrolled patients with plaque psoriasis…

Quelle: www.medpagetoday.com via Google News

Schreibe einen Kommentar